PharmaLectures.com

Courses › Regulatory affairs by region › Latin America: INVIMA, DIGEMID, ISP and ANMAT on one page

Latin America: INVIMA, DIGEMID, ISP and ANMAT on one page

Your Latin American dossiers pass first review in Colombia, Peru, Chile and Argentina.

  • 12 audio modulesthree lengths each
  • 2 h to 10 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • RA, QA, BDwho it is written for

Why this training matters

Your Registro Sanitario file reaches Colombia's National Food and Drug Surveillance Institute (INVIMA) with the manufacturing site details incomplete. The reviewer writes back, the launch date moves, and the same gap turns up again in your Peru filing.

What changes after this course

Your team files dossiers that hold up at first review in Colombia, Peru, Chile and Argentina, because each person has the checks for their own part. You hold a certificate for each learner and a training record for each person.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your Registro Sanitario file leaves your desk complete. You know what Decree 677 of 1995 expects from Colombia's National Food and Drug Surveillance Institute (INVIMA) and what Supreme Decree N° 016-2011-SA expects from Peru's General Directorate of Medicines, Supplies and Drugs (DIGEMID). Reviewers have no gap to write back about, because stability data and manufacturing site details are already in place.

Chile and Argentina stop being guesswork. For Chile's Institute of Public Health (ISP), you check a device against Decree 825/98 and catch the labelling slip before it is printed. For Argentina's National Administration of Drugs, Foods and Medical Technology (ANMAT), you align manufacturing records with Disposition 2069/2018 and put every renewal date in the calendar.

Cross-border paperwork is right the first time. Your staff drafts the power of attorney, checks the legalisation rule each agency applies, and presents the Certificate of Free Sale and the declaration of ingredients so that no assessor pauses the review to ask for them.

When an inspector arrives or a safety report falls due, the answer is ready. Your local safety officer knows the reporting timeline in each of the four countries, and your site manager hands over the records an INVIMA or DIGEMID inspector asks for.

Who needs this training

  • Regulatory Affairs Specialist

    You are about to send a Decree 677 dossier to INVIMA and you doubt the stability data and manufacturing site details will satisfy the reviewer. The checks are in your hands before you press send.

  • Quality Assurance Manager

    A DIGEMID inspector asks for a document nobody can find, or an ANMAT renewal date approaches and nobody owns it. You build the routine that has both answered before the day arrives.

  • Business Development Lead

    The board asks when the product reaches Chile, and you must name a date. You hear which steps the ISP medical device pathway under Decree 825/98 really involves, so your timeline rests on them.

Roles: Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: every kind of pharma company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Latin America

Courses are in English. Other languages on request.

After this course your people can

  1. Compile an INVIMA Registro Sanitario dossier that includes the manufacturing site details and stability data Decree 677 calls for.
  2. Prepare a DIGEMID drug registration under Supreme Decree N° 016-2011-SA, with the right forms signed by the químico farmacéutico.
  3. Check a medical device against Decree 825/98 and the ISP labeling criteria before the Chilean filing goes in.
  4. Align manufacturing records with ANMAT Disposition 2069/2018 and set a renewal calendar for the Certificado de Inscripción.
  5. Draft a power of attorney and present a Certificate of Free Sale to the standard each national agency applies.
  6. Tell a local safety officer which adverse event reporting timeline applies in Colombia, Peru, Chile and Argentina.
  7. Assemble the records an INVIMA or DIGEMID inspector asks for before the inspection starts.

What the company gets

  • Your regulatory department stops losing launch time to dossier gaps that a first reviewer spots at once.
  • Applications for INVIMA, DIGEMID, ISP and ANMAT go in with the same checks behind them, whoever on the team prepares them.
  • Local safety officers know their reporting dates, so adverse event reports reach the health authorities on time.
  • Site managers meet an inspector with the records in order and a straight answer to the first question.
  • Every learner has a certificate and a training record, so you can show an auditor who was trained and when.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 12 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard5 h25 min a module, for regulatory, quality and business-development staff
Expanded10 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Business development and export salesBriefing2 h
Regulatory affairsStandard5 h
Quality assurance and Qualified PersonStandard5 h

Course outline: 12 modules

12 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Match each product category to the national authority that regulates it

    • Why a filing sent to the wrong authority sits unread while your launch date slips.
    • How to sort a borderline product into its category before the first form is drafted.
    • What to tell the commercial team when a product falls under a different authority in each country.
  2. 2Clear INVIMA product approval and the Registro Sanitario steps

    • How to put your manufacturing practice evidence in the Colombian file on day one.
    • What to include in the Registro Sanitario file so the reviewer has no reason to write back.
    • The device classification error that parks a submission for months, and how to catch it before filing.
  3. 3Submit DIGEMID drug registrations under Supreme Decree N° 016-2011-SA

    • How Supreme Decree N° 016-2011-SA sets the order of your Peruvian drug registration file.
    • Which forms need the signature of your Peruvian technical director, the químico farmacéutico.
    • The missing document that sends a DIGEMID filing back to the start, and the check that finds it.
  4. 4Check ISP medical device requirements under Decree 825/98

    • How Decree 825/98 frames the control of medical devices in Chile.
    • How to show local testing or certificate recognition so the Chilean review does not stall.
    • The labelling slip that draws ISP attention to a medical device, and how to spot it first.
  5. 5Meet ANMAT guidelines under the current dispositions

    • How to line up your manufacturing practice records with ANMAT Disposition 2069/2018.
    • What to prepare for the Certificado de Inscripción so the first review does not end in rejection.
    • Why labeling errors in Argentina draw ANMAT scrutiny, and how to prevent them.
  6. 6Prepare the administrative documents every cross-border filing needs

    • How to draft a power of attorney that passes the legalisation rules of each agency.
    • The way to present a Certificate of Free Sale from your country of origin so no agency queries it.
    • Why the declaration of ingredients belongs in the file before the assessor starts.
  7. 7Build INVIMA pharmaceutical dossiers that meet Decree 677

    • What Decree 677 of 1995 expects to see in a Colombian pharmaceutical product dossier.
    • How to format stability study data so the reviewer accepts it on the first pass.
    • Which manufacturing site details to include so the dossier is not rejected outright.
  8. 8Direct DIGEMID biologic and biosimilar submissions with clinical data

    • How to lay out a biosimilar pathway that fits the DIGEMID rules for biological products.
    • The way to submit clinical trial data so the Peruvian review keeps moving.
    • Why the clinical data you attach shapes how DIGEMID reviews a biosimilar, and what to put first.
  9. 9Prepare ISP labeling and leaflets and check Chilean advertising rules

    • What Chilean rules ask of over-the-counter drug advertising before a campaign goes to print.
    • How to draft a local product leaflet that meets Chilean standards the first time.
    • The promotional material error that can open a sanitary proceeding in Chile.
  10. 10File ANMAT product variations and renewals on time

    • How ANMAT dispositions set the process for submitting changes to a registered product.
    • The renewal calendar that keeps any ANMAT renewal date from catching you by surprise.
    • Why late renewal documents put your market authorization in Argentina at risk.
  11. 11Manage post-market surveillance and pharmacovigilance reporting duties

    • How adverse event reporting timelines differ across Colombia, Peru, Chile and Argentina.
    • What your local safety officer must do in each market to keep reporting continuous.
    • The adverse event reporting failure that draws penalties, and the routine that prevents it.
  12. 12Answer INVIMA and DIGEMID inspections and queries on the spot

    • How to get your site ready for an INVIMA Good Manufacturing Practice inspection.
    • Which documents to have at hand for a DIGEMID inspection or audit.
    • Why a weak answer in an audit can lead to sanctions or a suspended product, and how to avoid it.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

12 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h in the briefing length and 10 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for RA, QA, BD. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 108 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team